No Data
No Data
Nexalin Technology Completes Phase 1of Its Innovative Virtual Clinic
Nexalin Files for Potential Stock Sale by Maxim Partners
Nexalin Technology Cut to Hold From Buy by Maxim Group
Nexalin Technology Analyst Ratings
Maxim Group Downgrades Nexalin Technology(NXL.US) to Hold Rating
New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market